Engineering a Novel Self-Assembled Multi-siRNA Nanocaged Architecture with Controlled Enzyme-Mediated siRNA Release

• Published in: ACS applied materials & interfaces Vol. 14; no. 51; pp. 56483 - 56497
• Main Authors: Moreno, Pedro M. D., Cortinhas, João, Martins, Ana S., Pêgo, Ana P.
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 28.12.2022
• Subjects: Biological and Medical Applications of Materials and Interfaces; Gene Silencing; RNA Interference; RNA, Small Interfering - chemistry; gene silencing; self-assembly; nanostructure; siRNA; conjugates
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.2c15086

The RNA interference (RNAi) chemical and structural design space has evolved since its original definitions. Although this has led to the development of RNAi molecules that are starting to address the issues of silencing efficiency and delivery to target organs and cells, there is an on-going interest to improve upon their properties to attain wider therapeutic applicability. Taking advantage of the flexibility given by DNA and RNA structural and chemical properties, we here investigated unconventional RNAi encoding structures, designated by caged-siRNA structures (CsiRNAs), to explore novel features that could translate into advantageous properties for cellular delivery and intracellular activity. Using the principles of controlled nucleic acid self-assembly, branched DNA–RNA hybrid intermediates were formed, ultimately leading to the assembly of a “closed” structure encompassing multiple RNAi units. The RNAi active regions are further triggered by an encoded RNAse H-mediated release mechanism, while the overall structure possesses easily addressable anchors for hybridization-based functionalization with active biological moieties. We confirmed the production of correct structures and demonstrated that the encoded RNAi sequences maintain gene silencing activity even within this novel unconventional nanoarchitecture, aided by the intracellularly triggered RNAse H release mechanism. With this design, functionalization is easily achieved with no negative effects on the silencing activity, warranting further development of these novel molecular structures as a multi-RNAi platform for therapeutic delivery.